""Intermediate
mammograms (IM) in breast screening offer potential benefits but
also disadvantages, like false positives (FP) results. Although
annual screening has not been shown to reduce more the mortality
than biennial screening, some studies have reported an increased
detection rate, detection of smaller tumours and a reduction in
interval cancers. On the other hand, in the whole IMs increase
the rate of FP. However in the case of younger women undergoing
their initial screen and those with risk factors (previous
invasive procedures, a family history of breast cancer or
hormone replacement therapy use) the risk of a FP result is
significantly lower. In order to guarantee the quality of
screening programmes, a better characterization of the IM
indications should be done, according to the presence of those
maximising benefits and minimising adverse effects" (Comment
on: Ascunce
N et al.: "Impact of intermediate mammography assessment on the
likelihood of false-positive results in breast cancer screening programmes",
Eur Radiol. 2011. [Epub ahead of print])
Discussion
-
Article in The
Lancet: MRI of little benefit to women with
breast cancer despite its increasing use. What do you think? Share your opinion on LinkedIn®
William
S Halsted (New York, 1852-1922), "The
results of radical operationsfor the cure of carcinoma of the breast", Ann Surg.
July 1907:46(1):1-19:“Fortunately we no longer need the
proof which our figures so unmistakably give that the slightest
delay is dangerous and that, other things being equal, the
prognosis is quite good in the early stage of breast cancer, two
in three being cured, and bad, three in four succumbing, when
the axillary glands are demonstrably involved"
Senology.org
collaborates with TalkAboutHealth.com
- "Breast cancer questions, answers, and support". Follow the Expert
Q&A Workshopsand join
the conversation
